Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in regulatory toxicology testing and risk assessment. This concept is similar to the Mode of Action (MOA), in that it describes a sequence of measurable key events triggered by a molecular initiating event in which a stressor interacts with a biological target. The resulting cascade of key events includes molecular, cellular, structural and functional changes in biological systems, resulting in a measurable adverse outcome. Thereby, an AOP ideally provides information relevant to chemical structure-activity relationships as a basis for predicting effects of structurally similar compounds. AOPs could potentially also form the basis for qualitative and quantitative predictive modeling of the human adverse outcome resulting from molecular initiating or other key events for which higher-throughput testing methods are available or can be developed. A variety of cellular and molecular processes are known to be critical for normal function of the central (CNS) and peripheral nervous systems (PNS). Because of the biological and functional complexity of the CNS and PNS, it has been challenging to establish causative links and quantitative relationships between key events that comprise the pathways leading from chemical exposure to an adverse outcome in the nervous system. Following introduction of the principles of MOA and AOPs, examples of potential or putative adverse outcome pathways specific for developmental or adult neurotoxicity are summarized and aspects of their assessment considered. Their possible application in developing mechanistically informed Integrated Approaches to Testing and Assessment (IATA) is also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The versatility and universality of calcium signalling
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Synaptic Activity and the Construction of Cortical Circuits
Katz, L. C., & Shatz, C. J. (1996) · Science · doi:10.1126/science.274.5290.1133 · Cited by 3,048 · cited 2×
“the developing brain (Katz and Shatz, 1996; Yuste and Bonhoeffer, 2001) is evidenced by the marked effect of experience on the development and refinement of synaptic connections, which not only patterns neural circuitry during development but also”
BackgroundRice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944 · cited 2×
“There is experimental evidence that increased neuronal apoptosis may also contribute to neurobehavioral deficits (Barone et al., 2000; Rice and Barone, 2000).”
BackgroundAnkley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Developmental neurotoxicity of industrial chemicals
Grandjean, P., & Landrigan, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69665-7 · Cited by 1,984
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775 · cited 1×
“BDNF serves essential functions in brain development and, more specifically, in synaptic plasticity (Poo, 2001), and is crucial for learning and memory processes (Lu et al., 2008).”
BackgroundRegulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586 · cited 1×
“2 that causes Timothy syndrome, which has a 60% rate of co-morbidity with autism (Splawski et al., 2004).”
BackgroundCa2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Autism spectrum disorders: developmental disconnection syndromes
Geschwind, D. H., & Levitt, P. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.009 · Cited by 1,411
Morphological Changes in Dendritic Spines Associated with Long-Term Synaptic Plasticity
Yuste, R., & Bonhoeffer, T. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1071 · Cited by 1,269
Patterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233 · cited 4×
“In mutant mice lacking PSD-95 (post-synaptic protein), increased NMDA-dependent LTP has been recorded that severely impairs spatial learning (Migaud et al., 1998).”
BackgroundInfluentialMigaud, M., Charlesworth, P., Dempster, M., Webster, L. C., Watabe, A. M., Makhinson, M., He, Y., Ramsay, M. F., Morris, R. G. M., Morrison, J. H., et al. (1998) · Nature · doi:10.1038/24790 · Cited by 1,160 · cited 1×
“In mutant mice lacking PSD-95 (post-synaptic protein), increased NMDA-dependent LTP has been recorded that severely impairs spatial learning (Migaud et al., 1998).”
BackgroundTrkB signalling pathways in LTP and learning
Minichiello, L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2738 · Cited by 1,055 · cited 1×
“Experimentally, it has been shown that activation of presynaptic TrkB receptors by BDNF also enhances glutamate release and increases the frequency of excitatory postsynaptic current (EPSCs) in hippocampal neurons derived from rat (Lessmann and Heumann, 1998; Takei et al., 1998; Minichiello, 2009).”
BackgroundZhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · cited 1×
“MeCP2 is a transcriptional repressor, and disruption of its function results in significant dendritic and synaptic dysregulation (Zhou et al., 2006).”
BackgroundZoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797 · cited 1×
“…substrate for many neurodevelopmental disorders, including autism spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD) and various intellectual disabilities (Bourgeron, 2009; Geschwind and Levitt, 2007; Judson et al., 2011; Penzes et al., 2011; Zoghbi and Bear, 2012).”
BackgroundRegulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C.-F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. M., Sharp, P. A., & Sheng, M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.005 · Cited by 735 · cited 1×
“…2011). miR132 has also been shown to interact with fragile X mental retardation protein (FMRP) to regulate synapse formation in experimental models (Edbauer et al., 2010), and more recently, expression of miR132 has been shown to be dysregulated in schizophrenia (Kim et al., 2010; Miller et al.,…”
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · cited 1×
“Furthermore, there is experimental evidence showing that loss of BDNF via genetic deletion or pharmacological manipulation impairs LTP (Patterson et al., 1996; Monteggia et al., 2004) and decreases learning and memory (Lu et al., 2008).”
BackgroundBourgeron, T. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.06.003 · Cited by 637 · cited 2×
“…substrate for many neurodevelopmental disorders, including autism spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD) and various intellectual disabilities (Bourgeron, 2009; Geschwind and Levitt, 2007; Judson et al., 2011; Penzes et al., 2011; Zoghbi and Bear, 2012).”
BackgroundA systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation
Tarpey, P. S., Smith, R., Pleasance, E., Whibley, A., Edkins, S., Hardy, C., O'Meara, S., Latimer, C., Dicks, E., Menzies, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.367 · Cited by 603
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome
Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., Cord, B., Palmer, T. D., Chikahisa, S., Nishino, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2576 · Cited by 585
Calmodulin-kinases: modulators of neuronal development and plasticity.
Wayman, G. A., Lee, Y.-S., Tokumitsu, H., Silva, A., & Soderling, T. R. (2008) · Neuron · doi:10.1016/j.neuron.2008.08.021 · Cited by 567
Calcium microdomains: Organization and function
Berridge, M. J. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.09.002 · Cited by 525
PSD-95 is required for activity-driven synapse stabilization.
Ehrlich, I., Klein, M., Rumpel, S., & Malinow, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609307104 · Cited by 470 · cited 1×
“Indeed, knockdown of PSD-95 (postsynaptic protein) blocks the functional and morphological development of glutamatergic synapses (Ehrlich et al., 2007).”
BackgroundWayman, G. A., Impey, S., Marks, D., Saneyoshi, T., Grant, W. F., Derkach, V., & Soderling, T. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.008 · Cited by 466 · cited 5×
“…to this AOP are studies demonstrating a causal link between increased intracellular Ca2+ levels and sequential activation of CaMKK, CaMKI and MEK/ERK to activate the transcription factor CREB, which then upregulates transcription of Wnt2 (Wayman et al., 2006) and miR132 (Impey et al., 2010).”
BackgroundInfluentialYang, J., Siao, C.-J., Nagappan, G., Marinic, T., Jing, D., McGrath, K., Chen, Z.-Y., Mark, W., Tessarollo, L., Lee, F. S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2244 · Cited by 449
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA
Klein, M. E., Lioy, D. T., Ma, L., Impey, S., Mandel, G., & Goodman, R. H. (2007) · Nature Neuroscience · doi:10.1038/nn2010 · Cited by 444
Rex, C. S., Lin, C.-Y., Kramár, E. A., Chen, L. Y., Gall, C. M., & Lynch, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4037-06.2007 · Cited by 324
Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P. J., Elsworth, J. D., Lawrence, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113793109 · Cited by 309
Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.002 · Cited by 298 · cited 1×
“…protein (FMRP) to regulate synapse formation in experimental models (Edbauer et al., 2010), and more recently, expression of miR132 has been shown to be dysregulated in schizophrenia (Kim et al., 2010; Miller et al., 2012), a disorder characterized by aberrant synaptic pruning (Woo, 2014).”
BackgroundRapid spine stabilization and synaptic enhancement at the onset of behavioural learning
Roberts, T. F., Tschida, K. A., Klein, M. E., & Mooney, R. (2010) · Nature · doi:10.1038/nature08759 · Cited by 296
An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling
Impey, S., Davare, M., Lasiek, A., Fortin, D., Ando, H., Varlamova, O., Obrietan, K., Soderling, T. R., Goodman, R. H., & Wayman, G. A. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.10.005 · Cited by 270 · cited 2×
“…to this AOP are studies demonstrating a causal link between increased intracellular Ca2+ levels and sequential activation of CaMKK, CaMKI and MEK/ERK to activate the transcription factor CREB, which then upregulates transcription of Wnt2 (Wayman et al., 2006) and miR132 (Impey et al., 2010).”
BackgroundMinding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity
Pessah, I. N., Cherednichenko, G., & Lein, P. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.009 · Cited by 231
Self-citationProgress toward treatments for synaptic defects in autism
Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013) · Nature Medicine · doi:10.1038/nm.3193 · Cited by 218
Yang, D., Kim, K. H., Phimister, A., Bachstetter, A. D., Ward, T. R., Stackman, R. W., Mervis, R. F., Wisniewski, A. B., Klein, S. L., Kodavanti, P. R. S., et al. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.11771 · Cited by 166
Self-citationWang, H., Chan, S.-A., Ogier, M., Hellard, D., Wang, Q., Smith, C., & Katz, D. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1810-06.2006 · Cited by 156
Rett Syndrome: Exploring the Autism Link
Percy, A. K. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.149 · Cited by 144
Jin, X., Hu, H., Mathers, P. H., & Agmon, A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05662.2003 · Cited by 137
PCB-95 Promotes Dendritic Growth via Ryanodine Receptor–Dependent Mechanisms
Wayman, G. A., Yang, D., Bose, D. D., Lesiak, A., Ledoux, V., Bruun, D., Pessah, I. N., & Lein, P. J. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104832 · Cited by 136
Self-citationWong, P. W., Brackney, W. R., & Pessah, I. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15145 · Cited by 124 · cited 3×
“PCB 95 potently sensitizes the RyR (Wong et al., 1997a; Wong and Pessah, 1996), which triggers a cascade of key cellular events that ultimately modulate neurodevelopmental processes that influence synaptic connectivity in the developing brain, specifically dendritic arborization, dendritic spine…”
BackgroundPutative adverse outcome pathways relevant to neurotoxicity
Bal-Price, A., Crofton, K. M., Sachana, M., Shafer, T. J., Behl, M., Forsby, A., Hargreaves, A., Landesmann, B., Lein, P. J., Louisse, J., et al. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.981331 · Cited by 114
Self-citationChen, C.-N., Liang, C.-M., Lai, J.-R., Tsai, Y.-J., Tsay, J.-S., & Lin, J.-K. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034634b · Cited by 112 · cited 1×
“EGCG interference with migration of rat NPCs was observed earlier (Chen et al., 2003).”
BackgroundEvolving Role of MeCP2 in Rett syndrome and Autism
LaSalle, J. M., & Yasui, D. H. (2009) · Epigenomics · doi:10.2217/epi.09.13 · Cited by 98 · cited 1×
“…humans, and both mutations and duplications of the gene have been associated with Rett syndrome and autism spectrum disorders (Cukier et al., 2012; LaSalle and Yasui, 2009; Percy, 2011). miR132 has also been shown to interact with fragile X mental retardation protein (FMRP) to regulate synapse…”
BackgroundCukier, H. N., Lee, J. M., Ma, D., Young, J. I., Mayo, V., Butler, B. L., Ramsook, S. S., Rantus, J. A., Abrams, A. J., Whitehead, P. L., et al. (2012) · Autism Research · doi:10.1002/aur.1251 · Cited by 89 · cited 1×
“…models and humans, and both mutations and duplications of the gene have been associated with Rett syndrome and autism spectrum disorders (Cukier et al., 2012; LaSalle and Yasui, 2009; Percy, 2011). miR132 has also been shown to interact with fragile X mental retardation protein (FMRP)…”
BackgroundLesiak, A., Zhu, M., Chen, H., Appleyard, S. M., Impey, S., Lein, P. J., & Wayman, G. A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2884-13.2014 · Cited by 88 · cited 5×
“PCB 95 activation of the CaMKI-CREBWnt2 signaling pathway is blocked by pharmacological antagonism of RyRs using FLA 365 or siRNA knockdown of RyR1 or RyR2 (Wayman et al., 2012a).”
BackgroundInfluentialSelf-citationPerinatal exposure to polychlorinated biphenyls alters social behaviors in rats
Jolous-Jamshidi, B., Cromwell, H. C., McFarland, A. M., & Meserve, L. A. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.08.015 · Cited by 72 · cited 1×
“Also supportive of this AOP are data showing that perinatal exposure to RyR-active PCB 47, albeit in combination with PCB 77, a congener with no effect on RyR activity, alters social behavior in rats (Jolous-Jamshidi et al., 2010).”
Cited by
Adverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
An ecotoxicological view on neurotoxicity assessment
Legradi, J. B., Di Paolo, C., Kraak, M. H. S., van der Geest, H. G., Schymanski, E. L., Williams, A. J., Dingemans, M. M. L., Massei, R., Brack, W., Cousin, X., et al. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0173-x · Cited by 254
Ciallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227
“107 Currently, AOPs are being developed for various types of toxicities such as acute inhalation toxicity, 108 neurotoxicity, 109–111 skin sensitization, 112–114 estrogen receptor bindings, 115,116 forestomach tumors not induced by genotoxic events, 117 and drug-induced cholestatic liver injury.”
BackgroundMembers, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124
“The adverse outcome pathway (AOP) concept organizes heterogeneous biological and toxicological data to provide information on possible sequences of events across multiple levels of biological organization (Bal-Price et al. 2017; Villeneuve et al. 2014a, b; Leist et al. 2017).”
BackgroundSelf-citationMasjosthusmann, S., Blum, J., Bartmann, K., Dolde, X., Holzer, A., Stürzl, L., Keßel, E. H., Förster, N., Dönmez, A., Klose, J., et al. (2020) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2020.en-1938 · Cited by 110
Self-citation
Metadata
- Authors
- Bal-Price, A., Lein, P. J., Keil, K. P., Sethi, S., Shafer, T., Barenys, M., Fritsche, E., Sachana, M., & Meek, M. E. (.
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 59
- Pages
- 240-255
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2394800948
- Cited by
- 94
- References
- 50
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.